Case studies: de novo application of Neoral in racially diverse recipients.
Pollak
R
R
Department of Surgery, University of Illinois at Chicago 60612-7213, USA.
D000284:Administration, Oral; D001741:Black or African American; D001379:Azathioprine / Q000627:therapeutic use; D044383:Black People; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D016595:Misoprostol / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D044465:White People
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016595:Misoprostol; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone